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AN ACUTE MODEL OF CYTOKINE-STIMULATED
ARTICULAR CARTILAGE DEGRADATION IN THE DOG
M.A. Pratta1, S.J. Hoffman1, F.L. Wang1, T. Newman-Tarr1,
R.W. Coatney2, J.B. Morris2, C.A. Capriotti1, J.L. McLane1,
K.S. Kilgore1, S. Kumar1
1GlaxoSmithKline Pharmaceutical Co., Collegeville, PA;
2GlaxoSmithKline Pharmaceutical Co., King of Prussia, PA
Purpose: To develop an acute model of articular cartilage degra-
dation in the dog for progression of pharmaceutical agents into
long term chronic models.
Methods: Canine cytokines were cloned and expressed as de-
scribed in a recent publication. All procedures were approved by
the GSK Institutional Animal Care and Use Committee. Articular
cartilage derived from various joints from Beagle dogs was iso-
lated and was either used in cartilage explant assays in organ
culture or as a source of primary chondrocytes. Chondrocytes
were evaluated in a cell-based aggrecanase assay based on a
published method. For in vivo studies, beagle dogs (n=4-6) were
anesthetized for both intra-articular (IA) injection and synovial
ﬂuid (SF) collection of the stiﬂe joint. Human or canine cytokines
were injected in one knee and vehicle into the contralateral. At
designated times, SF was collected by arthrocentesis; SF col-
lected 7 days pre-injection represented baseline control for each
animal. Total aggrecan content (GAG) of the SF was measured
using an alcian blue assay and aggrecanase-generated aggrecan
fragments (ARGSVIL) were measured by ELISA. Dogs were pro-
vided veterinary oversight during the in-life portion of the studies.
Results: Stimulation of canine articular chondrocytes and canine
cartilage explants with canine IL-1 resulted in induction of aggre-
canase activity and aggrecan degradation, respectively, whereas
IL-1α and β of human origin were ineffective. Interestingly, both
human and canine OSM induced aggrecanase activities and car-
tilage aggrecan degradation. Based on these in vitro ﬁndings, the
effects of cytokines on cartilage aggrecan degradation following
IA injection into the knee joints of beagle dogs were evaluated.
IA injection of canine IL-1β at doses between 1-200 ng resulted
in 3-legged lameness that was dose-dependent in severity and
duration. Therefore, the use of IL-1 was discontinued for ethical
concerns. However, IA injection of both human and canine OSM
at doses up to 1000 ng resulted in no detectable lameness and
joint effusion over that of vehicle alone. In addition, OSM injec-
tion caused increases in both GAG and the ARGSVIL aggrecan
fragment, and based on dose response studies, the optimal dose
of canine OSM was determined to be 200 ng/joint. Evaluation
of the time course following IA injection of 200 ng of OSM re-
sulted in GAG and the ARGSVIL-fragment levels that reached a
peak relative to the contralateral controls at 24 hours, and then
returned to vehicle levels by 48 hours post-injection. Because of
the acute nature of the cartilage aggrecan loss of this model,
repeated use of the same colony of dogs has been possible.
Conclusions: We have established an acute model of OSM-
stimulated cartilage degradation in the dog. This model has
utility to for screening of multiple pharmaceutical agents prior to
their evaluation in more long term chronic models in the dog or
other species.
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A PRECISE AND SCALABLE METHOD OF MICE KNEE
SYNOVIAL FLUID COLLECTION FOR USE IN
BIOMARKER ANALYSES
D.R. Seifer, B.D. Furman, F. Guilak, S.A. Olson, V.B. Kraus
Duke University, Durham, NC
Purpose: To develop methods for accurate recovery of the
approximate 1-µL of synovial ﬂuid (SF) present in a mouse
knees that would permit OA-related biomarker analyses.
Methods: Through an investigation into unique materials, poly-
acrylate beads (PAB) and the calcium sodium alginate compound
(CSAC) Melgisorb (Tendra, Goteborg) were identiﬁed as poten-
tial SF recovery vectors. The SF recovery efﬁciency of these
novel materials were compared against that of Whatman paper
(WPR), which has previously been used in larger (≥3-µL) appli-
cations. Once SF is absorbed by the PAB, it is recovered by the
addition and subsequent removal of 100-µL of saturated NaCl
solution. The optimal time course for maximal SF recovery using
the PAB recovery vector was determined through the mapping
of efﬁciency curves. In the case of CSAC, the addition of 35µL
of ﬂavobacterium-derived alginate lyase in H2O and 15µL 1.0M
Sodium citrate dissolved the alginate ﬁbers. The reﬁnement of a
small-volume measurement technique, termed “pipette-dialing”,
allows for the change in volume (dV) to be quantiﬁed in both
methods. Each method was assessed for human SF percent
retrieval of liquid volume (pipette dialing), total protein (Bradford
assay), and cartilage oligomeric matrix protein (COMP, ELISA
with monoclonal antibody 12C4). Based on the results of these
analyses, the CSAC method was tested in vivo. Upon sacriﬁce,
synovial ﬂuid was collected from both knees of twelve adult male
C57BL/6 mice, six of which had been given left knee articular
fractures. All of these mice were raised on a high fat (60%) diet.
COMP was measured in these samples using the 12C4 ELISA,
and all data were analyzed using SPSS statistical software.
Results: PAB volume recovery peaked at 5 minutes. Average
volume recovery ratios (Vrecovered/Vabsorbed) were found to be
0.987 + 0.367 and 1.00 + 0.502 for PAB and CSAC respec-
tively. With the WPR method, it was not possible to accurately
measure dV in sample sizes ≤3-µL. Lightly cross-linked PABs
(PSL), medium cross-linked PABs (PSM), and CSAC were more
efﬁcient (62.7%, 47.1%, and 27.1%) at recovering protein in
vitro from 1-µL of human SF than the highly cross-linked PABs
(PSH), which recovered only 20.59% of the total protein in 1-µL
of human SF; however, the PSL and CSAC procedures were
signiﬁcantly worse at protein recovery than the Whatman paper
method, which achieved >95% protein recovery in vitro (p<0.01)
(see Figure). CSAC was chosen for testing in vivo due to: 1)
the ability to precisely and accurately quantify the volume of
liquid recovered, 2) a lower, non-speciﬁc background in the 12C4
ELISA assay compared with PAB recovered samples, and 3) the
fact that it is easier than polyacrylate to physically manipulate
during in vivo trials. The mean COMP concentration of the frac-
tured left knees trended higher than that of the corresponding
non-fractured right knees in the same animals (3444+1515-ng/µL
versus 2924+1302-ng/µL, p=0.075 in a Wilcoxon Signed-Rank
Test). The concentration ratio ([COMPright knee]/[COMPleft knee])
was signiﬁcantly higher in the mice subjected to articular fracture
(p=0.026, Mann-Whitney U Test).
Conclusions: Even though the Whatman paper method was
most efﬁcient at protein recovery, its inability to measure dV
≤1-µL would prevent accurate biomarker determinations for in
vivo situations of limited (<3 µl) SF availability; therefore, the
